Emadine

Emadine is a brand name of emedastine ophthalmic, approved by the FDA in the following formulation(s):

EMADINE (emedastine difumarate - solution/drops; ophthalmic)

• 
  Manufacturer: ALCON
  
  Approval date: December 29, 1997
  
  Strength(s): 0.05% ^[RLD]

Has a generic version of Emadine been approved?

No. There is currently no therapeutically equivalent version of Emadine available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Emadine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Ophthalmic compositions comprising emedastine and methods for their use
  Patent 5,441,958
  Issued: August 15, 1995
  Inventor(s): Yanni; John M. & Robertson; Stella M. & Okumura; Shigetoshi & Tanaka; Hitoshi & Saito; Tadayuki
  Assignee(s): Alcon Laboratories, Inc.
  Topical ophthalmic compositions comprising 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole and its ophthalmically acceptable acid addition salts have been found to be useful in treating allergic conjunctivitis and related ailments.
  
  Patent expiration dates:
  
  
  • December 8, 2013
    
    ✓ 
    Patent use: TREATMENT OF ALLERGIC CONJUNCTIVITIS
  
  

See also...

• Emadine Drops Consumer Information (Wolters Kluwer)
• Emadine Consumer Information (Cerner Multum)
• Emadine Advanced Consumer Information (Micromedex)
• Emadine AHFS DI Monographs (ASHP)
• Emedastine Drops Consumer Information (Wolters Kluwer)
• Emedastine ophthalmic Consumer Information (Cerner Multum)
• Emedastine Ophthalmic Advanced Consumer Information (Micromedex)
• Emedastine Difumarate AHFS DI Monographs (ASHP)